• 1
    DiSaia PJ, Morrow CP, Boronow R, Creasman W, Mittelstaedt L. Endometrial sarcoma: lymphatic spread patterns. Am J Obstet Gynecol 1978; 130: 1045.
  • 2
    Omura GA, Blessing JA, Major FJ, Lifshitz S, Ehrlich CE, Mangan C, et al. A randomized trial of adjuvant Adriamycin in uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol 1985; 3: 12405.
  • 3
    Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathological spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 1987; 60: 203541.
  • 4
    Silverberg SG, Major FJ, Blessing JA, Fetter B, Askins F, Liao S, et al. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: a Gynecologic Oncology Group pathology study of 203 cases, Int J Gynecol Pathol 1990; 23: 119.
  • 5
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 45781.
  • 6
    Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 16370.
  • 7
    Segal MR, Bloch DA. A comparison of estimated proportional hazards models and regression trees. Stat Med 1989; 8: 53950.
  • 8
    Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.
  • 9
    Agresti A. Categorical data analysis. New York: John Wiley, 1990.
  • 10
    Hannigan EV, Freedman RS, Rutledge FN. Adjuvant chemotherapy in early uterine sarcoma. Gynecol Oncol 1983; 15: 5664.
  • 11
    Neilsen SW, Podratz KC, Schalthaver BW, O'Brien PC. Clinico-pathologic analysis of uterine malignant mixed mullerian tumors. Gynecol Oncol 1989; 34: 3728.